A. Murgo

发表

In silico modeling and in vivo efficacy of cancer-preventive vaccinations.

F. Pappalardo, S. Motta, P. Lollini, 2010, Cancer research.

Cancer esearch rated Systems and Technologies : Mathematical Oncology ilico Modeling and In vivo Efficacy of R cer-Preventive Vaccinations

F. Pappalardo, S. Motta, P. Lollini, 2010 .

Human responses against HER-2-positive cancer cells in human immune system-engrafted mice

P. Lollini, M. Iezzi, P. Nanni, 2012, British Journal of Cancer.

Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β2 Agonist (MABA) for the Inhaled Treatment of Respiratory Diseases.

S. Catinella, L. Venturi, P. Puccini, 2022, Journal of medicinal chemistry.

CHF6366: characterisation of the bronchoprotective effect of a novel MABA compound in the experimental bronchospasm model in anaesthetised guinea pigs

B. Riccardi, G. Villetti, A. Murgo, 2017 .

Antimetastatic activity of a preventive cancer vaccine.

P. Musiani, P. Lollini, M. Iezzi, 2007, Cancer research.

A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome.

P. Musiani, M. Penichet, P. Lollini, 2009, Human gene therapy.

Opposing control of rhabdomyosarcoma growth and differentiation by myogenin and interleukin 4

P. Lollini, P. Nanni, C. De Giovanni, 2009, Molecular Cancer Therapeutics.

Antimetastatic activity of a preventive cancer vaccine (Cancer Research (2007) 67, (11037-11044))

P. Musiani, P. Lollini, M. Iezzi, 2007 .

High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy.

P. Lollini, C. García-echeverría, K. Scotlandi, 2010, European journal of cancer.

Multiorgan Metastasis of Human HER-2+ Breast Cancer in Rag2−/−;Il2rg−/− Mice and Treatment with PI3K Inhibitor

P. Lollini, M. Iezzi, P. Nanni, 2012, PloS one.

the human immune system at a natural scale ImmunoGrid: towards agent-based simulations of

Patrice Duroux, Marie-Paule Lefranc, Ping Zhang, 2010 .

Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy.

P. Musiani, P. Lollini, M. Iezzi, 2009, Vaccine.

Discovery of a Potent, Selective, and Orally Bioavailable Tool Compound for Probing the Role of Lysophosphatidic Acid Type 2 Receptor Antagonists in Fibrotic Disorders.

A. Capelli, P. Puccini, G. Villetti, 2023, Journal of medicinal chemistry.

ImmunoGrid: towards agent-based simulations of the human immune system at a natural scale†

Massimo Bernaschi, Marie-Paule Lefranc, Ole Lund, 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines.

P. Lollini, P. Nanni, C. De Giovanni, 2011, Vaccine.

Harnessing the translational power of bleomycin model: new insights to guide drug discovery for idiopathic pulmonary fibrosis

G. Villetti, A. Murgo, M. Civelli, 2023, Frontiers in Pharmacology.